InterCure Ltd. Form 6-K Summary
Business context and reporting period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K on November 17, 2021 for the month of November 2021. The filing identifies exhibits covering the three- and nine-month periods ended September 30, 2021 and 2020. The provided filing text contains the cover page and exhibit index but not the underlying press releases, MD&A, or financial statements.
Financial metrics
The provided text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material changes versus the prior comparable period
The provided text does not describe changes versus the three- or nine-month periods ended September 30, 2020.
Guidance, outlook, risks, and unusual items
The provided text does not include management commentary, guidance, outlook, risk disclosures, contingencies, or unusual items. It indicates that these matters may be addressed in the referenced exhibits.
Important facts to verify
- Review Exhibit 99.1 and Exhibit 99.2, press releases dated November 15, 2021.
- Review Exhibit 99.3, MD&A for the three- and nine-month periods ended September 30, 2021 and 2020.
- Review Exhibit 99.4, unaudited interim condensed consolidated financial statements for the period ended September 30, 2021.
- Confirm the filing’s reported revenue, profitability, cash generation, liquidity, debt, operating trends, and any forward-looking statements in the referenced exhibits.